Covidien - Provider of Healthcare Products

Covidien, a leading global provider of healthcare products, partners with medical professionals around the world to develop innovative technologies, products and solutions for the healthcare industry. Covidien has been at the forefront of innovation, responsible for such breakthrough developments as pulse oximetry, mechanical ventilation, electrosurgery and laparoscopic instrumentation. Covidien’s partnerships with the medical community have also driven innovations in areas such as patient safety, medical accuracy, professional training, cancer treatment and cost containment. These strong partnerships help to reduce hospital-acquired infections, the time required in the operating room and costly medical errors. With these collaborations, Covidien delivers tangible solutions that save time and money, while meeting the demands of this ever-changing industry. With training and research facilities around the globe, Covidien works closely with medical professionals daily to improve patient outcomes and remains committed to developing solutions that will propel advances in the healthcare industry.

Examples of the Company’s recent innovations include the SILS™ Port Multiple Instrument Access Port for laparoscopic surgeries through a single incision; Duet TRS™ Reload, an endoscopic stapler preloaded with tissue reinforcement material; Permacol™ Biologic Implant, a biologic mesh for hernia and abdominal wall repair; and Kendall™ AMD Antimicrobial Foam Dressings, an advanced cost effective wound treatment proven effective against MRSA.

The Company recently announced two vascular products acquisitions and two pharmaceutical licensing agreements which will accelerate its growth. VNUS Medical Technologies and Bacchus Vascular will complement its market-leading line of vascular solutions. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions and has licensed two topical formulations of diclofenac, a non-steroidal anti-inflammatory drug (NSAID), as well as Exalgo Extended-Release Tablets, a formulation of the opioid analgesic hydromorphone.